STRO's valuation remains compelling despite recent market hits, with optimism for a turnaround driven by late-stage clinical trials and strong pipeline potential. Luveltamab tazevibulin shows ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Sutro Biopharma has a 1 year low of $1.70 and a 1 year high of $6.13. The business has a fifty day moving average of $2.98 and a 200-day moving average of $3.50.

Joann Sutro, a longtime resident of Oakland, died peacefully in hospice in Concord, CA, on September 19, 2024, at age 94. At the time of her passing, Joann lived at Belmont Village Senior Living ...